FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147582471> ?p ?o ?g. }

• W3147582471 endingPage "46" @default.
• W3147582471 startingPage "42" @default.
• W3147582471 abstract "Idiopathic nephrotic syndrome is a common nephropathy in children basically treated with corticosteroids and, in some cases, with cyclosporin A. There are concerns that proteinuria itself and cyclosporin A could cause renal fibrosis via activation of transforming growth factor beta (TGF-β), which may stimulate deposition of collagen type III, synthesised as procollagen III amino terminal propeptide (PIIINP). The aim of this study was to assess urinary TGF-β and PIIINP to creatinine (Cr) ratio as markers of renal fibrosis in children with idiopathic nephrotic syndrome put on corticosteroid and cyclosporin A treatment. Materials and methods: The study comprised 20 children with idiopathic nephrotic syndrome in remission on prednisone, aged 6.87 years [interquartile range (IQR): 6.37]; 21 children with idiopathic nephrotic syndrome in remission on cyclosporin A, aged 9.66 years (IQR: 5.0); and 21 healthy subjects, aged 7.16 years (IQR: 9.0). First morning urinary PIIINP/Cr and TGF-β/Cr were obtained and compared with Mann–Whitney U test, with the level of significance at p ≤ 0.05. Results: PIIINP/Cr ratio was significantly elevated in the cyclosporin A group [3.44 (2.5) vs. 1.12 (0.96) μg/mmol], p = 0.000, as well as in the prednisone group when compared to controls [1.33 (1.58) vs. 1.12 (0.96) μg/mmol], p = 0.042. The TGF-β/Cr ratio was significantly higher only in the cyclosporin A group when compared to controls [4.03 (3.25) vs. 2.33 (1.62) μg/mmol], p = 0.004. Conclusions: Increased urinary PIIINP/Cr ratio in children with idiopathic nephrotic syndrome either on steroid or on cyclosporin A therapy may suggest that renal fibrosis is a process generally involved in idiopathic nephrotic syndrome. Elevated urinary TGF-β/Cr and PIIINP/Cr ratios in patients with idiopathic nephrotic syndrome on cyclosporin A may reflect nephrotoxicity of this drug." @default.
• W3147582471 created "2021-04-13" @default.
• W3147582471 creator A5052175826 @default.
• W3147582471 date "2021-03-05" @default.
• W3147582471 modified "2023-09-26" @default.
• W3147582471 title "Urinary procollagen III aminoterminal propeptide/creatinine (PIIINP/Cr) ratio and transforming growth factor beta/creatinine (TGF-β/Cr) ratio in children with idiopathic nephrotic syndrome on corticosteroid and cyclosporine A treatment" @default.
• W3147582471 doi "https://doi.org/10.15557/pimr.2021.0006" @default.
• W3147582471 hasPublicationYear "2021" @default.
• W3147582471 type Work @default.
• W3147582471 sameAs 3147582471 @default.
• W3147582471 citedByCount "0" @default.
• W3147582471 crossrefType "journal-article" @default.
• W3147582471 hasAuthorship W3147582471A5052175826 @default.
• W3147582471 hasBestOaLocation W31475824711 @default.
• W3147582471 hasConcept C119060515 @default.
• W3147582471 hasConcept C126322002 @default.
• W3147582471 hasConcept C134018914 @default.
• W3147582471 hasConcept C2778720950 @default.
• W3147582471 hasConcept C2778930706 @default.
• W3147582471 hasConcept C2779561371 @default.
• W3147582471 hasConcept C2780091579 @default.
• W3147582471 hasConcept C2780306776 @default.
• W3147582471 hasConcept C71924100 @default.
• W3147582471 hasConcept C77411442 @default.
• W3147582471 hasConcept C90924648 @default.
• W3147582471 hasConceptScore W3147582471C119060515 @default.
• W3147582471 hasConceptScore W3147582471C126322002 @default.
• W3147582471 hasConceptScore W3147582471C134018914 @default.
• W3147582471 hasConceptScore W3147582471C2778720950 @default.
• W3147582471 hasConceptScore W3147582471C2778930706 @default.
• W3147582471 hasConceptScore W3147582471C2779561371 @default.
• W3147582471 hasConceptScore W3147582471C2780091579 @default.
• W3147582471 hasConceptScore W3147582471C2780306776 @default.
• W3147582471 hasConceptScore W3147582471C71924100 @default.
• W3147582471 hasConceptScore W3147582471C77411442 @default.
• W3147582471 hasConceptScore W3147582471C90924648 @default.
• W3147582471 hasIssue "1" @default.
• W3147582471 hasLocation W31475824711 @default.
• W3147582471 hasOpenAccess W3147582471 @default.
• W3147582471 hasPrimaryLocation W31475824711 @default.
• W3147582471 hasRelatedWork W177741517 @default.
• W3147582471 hasRelatedWork W2037483653 @default.
• W3147582471 hasRelatedWork W2077370951 @default.
• W3147582471 hasRelatedWork W2080530067 @default.
• W3147582471 hasRelatedWork W2157219243 @default.
• W3147582471 hasRelatedWork W2162362541 @default.
• W3147582471 hasRelatedWork W2338703557 @default.
• W3147582471 hasRelatedWork W2410260778 @default.
• W3147582471 hasRelatedWork W2432500247 @default.
• W3147582471 hasRelatedWork W63980913 @default.
• W3147582471 hasVolume "17" @default.
• W3147582471 isParatext "false" @default.
• W3147582471 isRetracted "false" @default.
• W3147582471 magId "3147582471" @default.
• W3147582471 workType "article" @default.